Streetbeat News

Products Services

FDOC

MDGS

Medigus Ltd. (NASDAQ:MDGS) announced that Revoltz Ltd., partially owned by Fuel Doctor Holdings, Inc. (OTC:FDOC), has entered an exclusive distribution agreement in the US for its advanced micro-mobility EVs with a leading distributor in the homeland security and law enforcement sector. The distributor committed to purchase a minimum of 500 units of PORTO, Revoltz's micro-mobility vehicles, in the coming year.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 11:58 am

BTTX

Better Therapeutics, Inc. (NASDAQ:BTTX) has announced the commercial launch of AspyreRx, the first cognitive behavioral therapy (CBT) app to receive FDA authorization as a Class II device to treat adults with type 2 diabetes. The app, backed by a randomized controlled trial, demonstrated significant reductions in A1c at 90 and 180 days, improvements in blood pressure, weight, mood, and quality of life, and lower medication utilization and fewer adverse events compared to the control group.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 11:56 am

COST

LQR House has announced that Von Payne Whiskey, one of its products, is now available at Costco due to its custom marketing campaign and strategic efforts.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 11:52 am

AMRC

Ameresco, Inc. (NYSE:AMRC) has announced a large-scale energy efficiency project with Schaeffler Aerospace Canada Inc. The project, which began in April 2023, involves the installation of a new high efficiency chiller & boiler system to serve new air handling units at Schaeffler's Stratford, Ontario plant site. The project will also update the existing Building Automation System to integrate control of all of the new High-Efficiency Heating, Ventilation and Air Conditioning (HVAC) System HVAC equipment.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 11:52 am

JNPR

The North American Network Operators' Group (NANOG) has announced a partnership with Juniper Networks, making Juniper the official provider of routing solutions for NANOG's annual conferences.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 11:49 am

APTO

Aptose Biosciences has announced that two abstracts on Tuspetinib, a Phase 1/2 Myeloid Kinase Inhibitor for Acute Myeloid Leukemia, have been accepted for poster presentations at the European School of Haematology International Conference.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 11:47 am

CGTX

Cognition Therapeutics, Inc. (NASDAQ:CGTX) announced presentations from studies of CT1812, its lead candidate for Alzheimer's treatment, at the CTAD conference. The findings showed that CT1812 had a beneficial impact on synapse function and improved brain communication. The company will also discuss the Phase 2 study design of the ongoing START study, which is enrolling adults with early Alzheimer's disease.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 11:36 am

XAIR

Beyond Cancer, an affiliate of Beyond Air, has announced new preclinical data supporting the company's UNO therapy for various types of solid tumors. The therapy is effective as a single agent and in combination with checkpoint inhibitors.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 11:36 am

GILD

Gilead Sciences will present new data at the European Society for Medical Oncology Congress 2023, including three oral presentations. The data includes real-world evidence and new clinical analysis supporting the role of Trodelvy in metastatic breast cancers, and its potential in small cell lung cancer, urothelial cancer, and head and neck cancers. Additionally, two new analyses will estimate treatment effects of Yescarta versus bispecific antibodies in relapsed/refractory diffuse large B-cell lymphoma.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 11:34 am